Figure 2.

Inhibition of pharmaceutically relevant transporters described in the FDA guidance²⁰ by the antivirals tilorone, quinacrine and pyronaridine. Compounds were tested at 10 μM for the ability to inhibit the transport of fluorescent substrates in cell-based assays. *Indicates these compounds were tested at 20 μM, and these results were previously published.²⁴